These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9794705)
1. Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis? Douma CE; de Waart DR; Struijk DG; Krediet RT J Lab Clin Med; 1998 Oct; 132(4):329-40. PubMed ID: 9794705 [TBL] [Abstract][Full Text] [Related]
3. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide? Douma CE; de Waart DR; Struijk DG; Krediet RT Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD. Douma CE; de Waart DR; Zemel D; Struijk DG; Krediet RT Nephrol Dial Transplant; 2001 Apr; 16(4):803-8. PubMed ID: 11274278 [TBL] [Abstract][Full Text] [Related]
5. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688 [TBL] [Abstract][Full Text] [Related]
6. Nitrate in stable CAPD patients and during peritonitis. Douma CE; de Waart DR; Zemel D; Imholz AL; Koomen GC; Struijk DG; Krediet RT Adv Perit Dial; 1995; 11():36-40. PubMed ID: 8534733 [TBL] [Abstract][Full Text] [Related]
7. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412 [TBL] [Abstract][Full Text] [Related]
8. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis. Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393 [TBL] [Abstract][Full Text] [Related]
9. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD. Zemel D; Betjes MG; Dinkla C; Struijk DG; Krediet RT Perit Dial Int; 1995; 15(2):134-41. PubMed ID: 7612733 [TBL] [Abstract][Full Text] [Related]
10. Effect of indomethacin on peritoneal protein loss in a rabbit model of peritonitis. Peng H; Cheung AK; Reimer LG; Kamerath CD; Leypoldt JK Kidney Int; 2001 Jan; 59(1):44-51. PubMed ID: 11135056 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis. Steinhauer HB; Schollmeyer P Kidney Int; 1986 Feb; 29(2):584-90. PubMed ID: 3457982 [TBL] [Abstract][Full Text] [Related]
12. Free-water transport in fast transport status: a comparison between CAPD peritonitis and long-term PD. Smit W; van den Berg N; Schouten N; Aikens E; Struijk DG; Krediet RT Kidney Int; 2004 Jan; 65(1):298-303. PubMed ID: 14675063 [TBL] [Abstract][Full Text] [Related]
13. Substrate and inhibitor for nitric oxide synthase during peritoneal dialysis in rabbits. Douma CE; Zweers MM; de Waart DR; van der Wardt AB; Krediet RT; Struijk DG Perit Dial Int; 1999; 19 Suppl 2():S358-64. PubMed ID: 10406547 [TBL] [Abstract][Full Text] [Related]
14. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Krediet RT; Zuyderhoudt FM; Boeschoten EW; Arisz L Eur J Clin Invest; 1987 Feb; 17(1):43-52. PubMed ID: 3106050 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719 [TBL] [Abstract][Full Text] [Related]
16. Changes in water transport across the peritoneum during treatment with continuous ambulatory peritoneal dialysis in selected patients with and without peritonitis. Radtke M; Albrektsen GE; Widerøe TE; Nilsen TI; Romundstad P; Hallan S; Aasarød K; Laegreid IK; Oien C Perit Dial Int; 2004; 24(6):571-9. PubMed ID: 15559487 [TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis. Davenport A; Fernando RL; Varghese Z Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes. Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887 [TBL] [Abstract][Full Text] [Related]
19. Fibronectin during CAPD-related peritonitis: no indications for intraperitoneal production. Zemel D; Koomen GC; Struijk DG; Krediet RT Blood Purif; 1993; 11(6):378-83. PubMed ID: 8043259 [TBL] [Abstract][Full Text] [Related]
20. Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Yang CW; Hwang TL; Wu CH; Lai PC; Huang JY; Yu CC; Shyr MH; Huang CC Nephrol Dial Transplant; 1996 Dec; 11(12):2466-71. PubMed ID: 9017624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]